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ABSTRACT 
Malaria is the most important parasitic disease of subtropical and tropical countries and its control remains serious challenge, 
especially through the development of parasite resistance to standard antimalarial drugs. Aqueous and methanol leaves extract 
of Glyphaea brevis were investigated for their activities against malaria infections using albino mice infected with Plasmodium 
berghei at dose levels of 100mg/kg, 200mg/kg and 300mg/kg per day. Artemisinin at 5mg/kg /day was used as standard control. 
Dose dependent chemo-suppression of the parasites was obtained at different dosages of the tested extract. The methanol extract 
was found to be more active in parasite inhibition growth than its aqueous counterpart. In the established infected control group, 
aqueous and methanol extracts both showed significant dose dependent (P< 0.05) inhibitory and suppressive activities on the 
extracts treated animals when compared with the infected (positive) control groups. The percentage suppression revealed that 
400 mg/kg methanol extract treated group had the highest efficacy (81.89%) amongst the various dosages administered. There 
was reduction in PCV levels in all the Plasmodium berghei infected mice when compared to the normal control group. Also, 
there were significant (P< 0.05) increase in the serum concentration of alanine aminotransferase (80.75 ± 7.04) and aspartate 
aminotransferase (68.50 ± 4.66) of the infected control group compared to normal, standard and the extract treated groups. There 
was significant difference in the serum concentration of alkaline phosphatase in the positive control group and aqueous extract 
treated groups. Conclusively, aqueous and methanol leaves extracts of G. brevis possess antiplasmodial activity. 
  
Keywords: Antiplasmodial, Plasmodium berghei; Glyphaea brevis; Malaria suppression, Tropical disease 
 
*Author for correspondence: E-mail: tayoanjuwon@gmail.com; Tel. +2348066917667 
 
Received: June 2019; Accepted: August, 2019 
 
Abstracted by: 
Bioline International, African Journals online (AJOL), Index Copernicus, African Index Medicus (WHO), Excerpta medica 
(EMBASE), CAB Abstracts, SCOPUS, Global Health Abstracts, Asian Science Index, Index Veterinarius 
INTRODUCTION 
 
Malaria is a parasitic protozoan’s disease belonging to the 
plasmodium species (WHO, 2014) (Plasmodium falciparum, 
P. ovale, P. malariae, P. vivax, and P. knowlesi parasites) 
with P. falciparum being the leading one responsible for 
human infection. About 3.3 billion people worldwide are at 
risk of malaria (Taek and Agil, 2018). Malaria arguably 
remains the world most important tropical disease with 
prevalence and endemicity in 91 countries (Kager, 2002). It 
remains a critical health difficulty in Sub-Saharan Africa 
despite the huge progress that has been made in treatment and 
or management of the disease. The number of persons that 
were infected in Sub-Saharan Africa was estimated to be 114 
million in 2015; children who are mainly susceptible 
accounted for more than two-thirds of global malaria deaths 
(WHO, 2016). The main explanations for this worsening 
situation are therapy hitches: resistance to the current 
antimalarial drugs, unaffordability and or unavailability of 
antimalarial drugs and lack of new therapeutic targets (Jeruto 
et al., 2015). 
 Investigation of medicinal plants used traditionally for 
malaria treatment is on the increase (Philip et al., 2017). 
Medicinal plants have undoubtedly been a rich source for new 
drugs and some antimalarials - quinine and artemisinin, that 
are been used today. An estimate of about 122 drugs from 94 
plant species have been revealed via ethnobotanical leads. 
Plants commonly used in traditional medicine are assumed to 
be safe due to their long usage in the treatment of diseases 
according to knowledge accumulated over centuries. 
Therefore, the search for new drugs through the evaluation and 
validation of traditional medicines offers a good opportunity 
for the discovery and development of better medicines (Jeruto 
et al., 2015). Therefore, medicinal plants have remained the 
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main focus for scientists and researchers in the development 
of new antimalarial agents (Zeleke et al., 2017).  
 Glyphaea brevis is a shrub belonging to Tiliaceae family. 
In Africa and South America, it is used traditionally in the 
treatment of various disease conditions like fevers, 
gonorrhoea, dysentery, stomach troubles, lung troubles, 
parasitic infections, convulsions and constipation. In recent 
years, it has come under the lime light of researchers in various 
parts of the world due to its broad ethno-medicinal uses. This 
has made this plant an integral part of folkloric medicine in 
most parts of these regions. Remarkable rise in research on G. 
brevis has led to the establishment of some of its secondary 
metabolites to possess anti-proliferative, antioxidant and anti-
inflammatory activities in in vivo and in vitro assay 
procedures. However, to the best of the knowledge of the 
authors, there is no existing report on the comparative studies 
on the antiplasmodial activities of this plant on P. berghei 
infected mice. Hence, the present study was undertaken to 
evaluate the comparative antimalarial and toxicological 
effects of aqueous and methanol extracts of Glyphaea brevis 
in experimental malaria mice models (Osafo and Boakye, 
2016). 
 
MATERIALS AND METHODS 
 
Ethical consideration: This work was performed according 
to the approved guidelines of animal experiments of the 
Ethical Committee, Ahmadu Bello University (ABU) 
Committee on Animal Use and Care (ABUCAUC), Zaria, 
Nigeria  
 
Plant Sample: Glyphaea brevis leaves were gathered from 
Irun Akoko, Ondo State; identified at the herbarium unit of 
Botany Department, Ahmadu Bello University (ABU), Zaria 
with voucher specimen number 2634 obtained for future 
reference. The leaves were thoroughly washed in clean water, 
shade-dried and ground into powder. 
 
Experimental animals: Forty-five mice weighing between 
15-30g were used for the study. The animals were purchased 
from Department of Pharmacology, A.B.U, Zaria. The mice 
were housed in well-ventilated cages and fed on commercial 
laboratory diet and water ad libitum. 
 
Parasites: Sample of Plasmodium berghei was obtained from 
the Department of Veterinary Parasitology and Entomology, 
A.B.U, Zaria. 
 
Solvent Extraction of Plant Samples: Powdered leaves of G. 
brevis (100grams) each were extracted separately with 500mls 
of distilled water and 500mls of methanol using cold 
maceration and left for 48 hours. The aqueous extract was 
sieved and filtered, evaporated to dryness on a hot water bath 
at 45°C. The methanol extract was sieved and filtered, solvent 
were recovered using rotary evaporator and later evaporated 
to dryness. The extracts were kept in suitable containers until 
further use. The extracts were administered via oral route 
using a cannula curved in a manner that enables smooth 
administration and as well avoid wastage. 
 
Lethal Dose Determination for both Aqueous and 
Methanol Extracts: The median lethal dose (LD50) of the 
plant extracts were conducted using a standard method as 
previously described (Lorke, 1983).  
 
Inoculation of mice and Monitoring of infection: The blood 
from the donor mice was diluted with the same amount of 
normal saline so that each 0.2ml contained approximately 106 
– 107 infected red cells which is expected to produce a steadily 
rising infection in the test group mice (Ogbonna et al., 2008). 
Thin blood smears were made, Giemsa stained and viewed 
under a light microscope. The parasitaemia level was 
estimated by counting infected erythrocytes against normal 
erythrocytes in random fields of the (x100) microscope with 
the formula: 
% 𝑝𝑎𝑟𝑎𝑠𝑖𝑡𝑎𝑒𝑚𝑖𝑎 
=   
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑓𝑒𝑐𝑡𝑒𝑑 𝑅𝑒𝑑 𝐵𝑙𝑜𝑜𝑑 𝐶𝑒𝑙𝑙𝑠
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑅𝑒𝑑 𝐵𝑙𝑜𝑜𝑑 𝐶𝑒𝑙𝑙𝑠
 ×  100 
 
The mean % parasitaemia recorded for each mouse and for 
each group was used to determine variations in parasitamia 
level with time of infection (Okokon et al., 2008, Oyewole et 
al., 2008) 
 
Comparison of the antiplasmodial efficacy of Aqueous and 
Methanol extracts: A total of 45 mice randomized into nine 
(9) groups of five mice each were used in this experiment. 
Group I: Uninfected with parasite and untreated with extract 
(normal control) 
Group II: Infected with parasite and treated with 0.2ml of 
normal saline (Positive control) 
Group III: Infected with parasite and treated with 5 mg/kg 
Artemisinin (Standard control) 
Group IV: Infected with parasite and treated with 200 mg/kg 
aqueous extract. 
Group V: Infected with parasite and treated with 200 mg/kg 
methanol extract. 
Group VI: Infected with parasite and treated with 300 mg/kg 
aqueous extract. 
Group VII: Infected with parasite and treated with 300mg/kg 
methanol extract. 
Group VIII: Infected with parasite and treated with 400 
mg/kg aqueous extract. 
Group IX: Infected with parasite and treated 400 mg/kg 
methanol extract. 
 
In vivo antiplasmodial studies: The antimalarial activity of 
the plant was evaluated by its suppressive antiplasmodial 
properties in-vivo using standard method as previously 
described (Adzu et al., 2003) 
The percentage suppression of the parasite was evaluated with 
the equation below: 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑆𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =  
𝐴𝑃𝐶 –  𝐴𝑃𝑇
𝐴𝑃𝐶
  ×  100 
APC = Average Parasitaemia in the Positive Control, 
APT = Average Parasitaemia in the Test group 
 
Blood Samples Collection and Preparation: At the end of 
the experiments, the mice were anaesthetized and sacrificed, 
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blood samples were collected, centrifuged and used for further 
analyses. 
 
Determination of Biochemical Parameters: At the end of the 
experiments, animals were sacrificed and blood samples were 
collected. Blood plasma was used for PCV estimation using a 
microhaematocrit method (Alexander, 1993). The blood was 
centrifuged and the serum harvested was used for further 
analyses. Aspartate aminotransferase, (AST), alanine 
aminotransferase (ALT) and alkaline phosphatase (ALP) were 
determined using standard methods as previously described 
(Reitman and Frankel, 1957, Haussament, 1977) 
 
Statistical analysis: Data obtained were expressed as mean ± 
standard deviation (SD) and analyzed by one way analysis of 
variance (ANOVA). The difference between means were 
compared using Post-Hoc Duncan Multiple Range Test. 





Parasitaemia and Suppression Activities of Aqueous and 
Methanol Glyphaea brevis extracts on Plasmodium berghei 
Parasites 
The aqueous and methanol extracts of Glyphaea brevis leaves 
both showed significant dose dependent (p < 0.05) 
parasitaemia and suppressive activities on treated animals 
when compared with the infected (positive) control groups 
(Table 1). 
 
Packed Cell Volume (PCV) of Experimental Mice before 
and after Infection and Treatment 
Before the commencement of the study, the initial packed cell 
volume (PCV) of the experimental animals were determined 
and this showed no significant (P > 0.05) difference in all the 
groupings. However when they were infested with 
Plasmodium berghei parasite and treated, normal control 
animals showed a significant difference (P < 0.05), having the 
highest PCV compared to the rest of the experimental mice.  
 
Effect of the Aqueous and methanol Leaves Extracts of 
G. brevis on Body Weight of Mice before and after 
Infection and Treatment 
The result for the average change in body weight of the 
experimental mice before and after 
infection and treatment is shown in Fig 1. The average body 
weight of the mice in the normal and standard control groups 
showed significant increase, whereas the positive control 
group, aqueous and methanol extracts treated groups showed 
non-significant difference (P > 0.05) between their weight 
before and after treatment
 
 
Table 1:  
Parasitaemia and Suppression Activities of Aqueous and Methanol Glyphaea brevis extracts on Plasmodium berghei Parasites 
TREATMENT DOSE (mg/kg) % Parasitaemia % Suppression 
Normal Control - 0.00 ± 0.00a - 
Positive Control - 3.07 ± 0.23e - 
Standard Control 5mg/kg (Artemisinin) 0.29 ± 0.08b 90.49 
 
Aqueous Extract 
200mg/kg 1.07 ± 0.05d 65.15 
300mg/kg 0.67 ± 0.05c 78.27 
400mg/kg 0.69 ± 0.07c 77.69 
 
Methanol Extract 
200mg/kg 0.67 ± 0.07C 78.05 
300mg/kg 0.66 ± 0.04c 78.50 
400mg/kg 0.56 ± 0.64bc 81.89 
Values are expressed as Mean ± SD; and in percentages. 
Values with different superscript down the column are significant (P<0.05)
Table 2:  
Packed Cell Volume (PCV) of the Experimental Mice before and after Infection and Treatment 
Groupings DOSE (mg/kg) Initial PCV Final PCV 
Normal Control - 47.17 ± 2.52a 49.63 ± 4.65 c 
Positive Control - 54.33 ± 2.83a 44.37 ± 5.49abc 
Standard Control 5mg/kg (Artemisinin) 46.20 ± 0.00a 46.20 ± 2.62bc 
 
Aqueous Extract 
200mg/kg 50.43 ± 6.98a 38.07 ± 6.06 ab 
300mg/kg 54.57 ± 4.36a 46.23 ± 5.33bc 
400mg/kg 48.53 ± 7.39a 35.63 ± 7.62a 
 
Methanol Extract 
200mg/kg 50.33 ± 0.58a 44.07 ± 6.65abc 
300mg/kg 47.67 ± 6.81a 39.40 ± 2.26ab 
400mg/kg 49.90 ± 7.39a 41.73 ± 3.04abc 
Values are expressed as Mean ± SD; and in percentages. 
Values with different superscript down the column are significant (P<0.05). 
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Figure 1:  
Average change in weight of the experimental animals before infections, and after infections and treatment 
 
 
Table 3:  
Effect of Aqueous and Methanol Extracts of Glyphaea brevis Leaves on the Hepatic Marker Enzymes in Plasmodium berghei 
Infected Mice 
TREATMENT DOSE (mg/kg) ALT (IU/L) AST(IU/L) ALP (IU/L) 
Normal Control - 56.20 ± 8.04a 46.80 ± 6.18 bc 56.25 ± 6.60 a 
Positive Control - 80.75 ± 7.04b 68.50 ± 4.66 d 72.75 ± 7.50 b 




200mg/kg 60.75 ± 3.30a 36.33 ± 3.06 a 63.00 ± 5.72 a 
300mg/kg 64.00 ± 5.57a 50.00 ± 7.07 bc 52.67 ± 11.59 a 




200mg/kg 53.25 ± 5.74a 36.50 ± 8.74 a 64.75 ± 5.25ab 
300mg/kg 64.50 ± 6.86a 47.00 ± 8.76 bc 61.25 ± 6.56ab 
400mg/kg 62.67 ±4.04a 56.67 ± 4.16 c 65.67 ± 4.93ab 
Values are expressed as mean ± SD (standard deviation).Values with different superscripts down the columns are significantly 
different (p < 0.05); where ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase 
 
 
Effect of Aqueous and Methanol Extracts of Glyphaea 
brevis Leaves on Hepatic Marker Enzymes in Plasmodium 
berghei Infected Mice 
The result as presented in Table 3, revealed that there were  
significant (P < 0.05) increase in serum concentration of 
alanine aminotransferase (ALT) (80.75 ± 7.04) and serum 
aspartate aminotransferase (AST) (68.50 ± 4.66) compared to 
normal, standard and the extract treated groups. There was 
significant difference in the serum concentration of Alkaline 
phosphatase in the positive control group and aqueous extract 
treated groups, however there was no distinct statistical 
difference (P > 0.05) between the positive control group 
(72.75 ± 7.50) and the standard control group (59.75 ± 12.68) 
as well as the various groups administered different dosages 
of methanol extract. 
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DISCUSSION 
 
The positive control group (i.e. infected and left untreated) had 
highest level of parasitaemia (3.07 ± 0.23) while the 
Artemisinin treated group had the least (0.29 ± 0.08) 
parasitaemia. The percentage suppressive effect of the two 
extracts revealed that 400 mg/kg methanol extract treated 
group had the highest efficacy (81.89%) amongst the various 
dosages administered. The Artemisinin, which is a known 
drug for malaria treatment had 90.49% suppression on the 
parasites. 
 The superior performance noticed for artemisinin when 
compared with the extract in this study concurred with report 
of Matsuoka et al. (Matsuoka et al., 2000), that when a 
standard antimalarial drug is used in the management of 
Plasmodium berghei in mice, it suppresses parasitaemia. The 
highest percentage chemo-suppression activity of artemisinin 
recorded in the study showed that it still serves as effective 
antimalarial drug (Fidock et al., 2004).  Although the 
suppression of parasitaemia was never complete (100% 
inhibition of parasite growth), the aqueous and methanol 
extracts both showed antiplasmodial effects with methanol 
extract showing better result. The antiplasmodial potency of 
this plant could be as result of its phytochemical composition 
which have been established to have antimalarial activities 
(Anjuwon et al., 2015).  
 Glyphaea brevis may elicit its antimalarial effect through 
one or a combination of the mechanisms of action that have 
been proposed for antimalarial compounds isolated from 
plants; these are: inhibition of hemozoin polymerization in the 
parasite; intercalation with the parasite DNA; inhibition of 
Plasmodium falciparum lactate dehydrogenase (pfLDH); 
alkylation; inhibiting the formation of mobile microgametes; 
inhibition of proteolytic processing of circumsporozoite 
protein (Adebayo and Krettli, 2011). 
 The decrease in PCV observed in mice in negative control 
and extract administered groups are expected and this agreed 
with the research of Balogun et al. (Balogun et al., 2009), that 
the growing parasite consumes and degrades the intracellular 
proteins which are mainly haemoglobin, a major constituent 
of red blood cells. 
 The reduction in body weight in the group administered 
with extracts as well as the infected control group may be due 
to combined effect of plasmodial infection and possible 
catabolic effect of the extract on stored lipids and or short 
duration of the experiment (Zeleke et al., 2017, Alli et al., 
2011) 
 Liver injury can affect metabolic activities in the body due 
to its role in general metabolism. Within an hour of 
plasmodium infection, degenerative changes in the 
hepatocytes occurs due to invasion of the liver cells by 
Plasmodium, this may significantly alter the levels of serum 
liver marker enzymes. This study probed the possible effect of 
G. brevis in ameliorating this cellular damage. Alanine 
aminotransferase (ALT), aspartate aminotransferase (AST) 
and alkaline phosphatase (ALP) are considered indicators of 
hepatocellular health (Yang and Chen, 2003). A significant 
increase in the activities of ALT, AST and ALP in the blood 
serum of control parasitized mice as compared with all the 
other groups was observed. The observed increase in enzyme 
activities may be as a result of liver injury and altered 
hepatocyte integrity caused by the Plasmodium infection and 
the consequent release of these enzymes into the bloodstream. 
Serum elevations of ALT, AST and ALP activities are rarely 
observed except in parenchymal liver disease, muscular 
dystrophy, and organ damage; ALT is a more liver-specific 
enzyme than AST. The administration of G. brevis tends to 
normalize these enzymes (ALT, AST and ALP) activities 
which is in agreement with a reported investigation (George 
et al., 2011). This plant is extensively considered as 
vegetables. Treatment with extract from this study has shown 
to protect hepatocyte integrity of parasitized mice. 
 In conclusion, aqueous and methanol leaves extracts of 
Glyphaea brevis showed significant antiplasmodial activities 
making it a good candidate for the development of new 
antimalarial. Additional research should be carried out on the 
isolation and characterization of the components responsible 
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